13/02/2026
【回應超高齡社會挑戰，公私協力共築社會韌性】
美國商會2月3日舉辦「健康台灣樂齡論壇」，產官學研醫界攜手探討超高齡社會所面臨的挑戰與機會。
在人口結構轉變下，除慢性病管理外，急性感染帶來的風險同樣不容忽視。新冠病毒週期性流行再度提醒我們：及早診斷與及時治療對長者健康至關重要。也因此，在健康老化的理念下，醫療模式正從疾病治療，涵蓋到全齡預防與健康促進。
台灣輝瑞堅信創新能夠改變生命，期盼共同打造一個更健康的樂齡社會。我們也深信，透過公私協力可強化醫療體系與社會的韌性，攜手迎戰超高齡社會挑戰。
【Responding to the Challenges of a Super-Aged Society Through Innovation: Public–Private Collaboration to Build Social Resilience】
AmCham Taiwan held the "Healthy Aging Forum" on February 3, with representatives from industry, government, academia, research, and healthcare working together to explore the challenges and opportunities of a super aged society.
As demographic structures shift, the risks posed by acute infections—alongside chronic disease management—cannot be overlooked. The cyclical resurgence of COVID 19 once again underscores the importance of early diagnosis and timely treatment, which are critical to safeguarding the health of older adults. Guided by the principles of healthy aging, the healthcare model is evolving beyond disease treatment to encompass prevention and health promotion across all ages.
Pfizer Taiwan firmly believes that innovation can change lives and is committed to building a healthier, more vibrant aging society. We also believe that public–private collaboration can strengthen both the healthcare system and societal resilience, enabling us to jointly address the challenges of a super aged society.
#健康台灣 #公私協力
